Constant, Quebec) of either sex, weighing 300-40() g at the beginning of the immunisation, were used throughout the experiments. They were maintained on a normal laboratory diet.
IMMUNOGEN PREPARATION
An intestinal protein immunogen (mucosal antigen: MA) was prepared from whole small intestine by modification of the procedure described by Forstner et al. 5 Briefly, the postmicrosomal supernatant of guinea pig mucosal scrapings was applied to a 2*5x40 cm column of Bio-Gel A-15 (Bio-Rad, Richmond, California) and eluted with 20 mM Tris-H Cl-Na Cl buffer pH 8-0. The major 254 and 280 nm peak fractions were dialysed against distilled water and lyophilised. The powder was diluted in 10 ml of the same buffer, added to a 2 6x 100 cm column of Sephacryl S-200 Super fine (Pharmacia, Uppsala, Sweden) and eluted with the above mentioned buffer. Three ml fractions were collected with a LKB 7000 Ultrorac fraction collector (LKB, Autoimmune enterocolitis in guinea pigs 280 nm. Three peaks were obtained. The major peak eluting near the void volume was used as mucosal antigen immunogen after dialysis and lyophilisation. Protein concentration was measured by the method of Lowry et al.6 IMMUNISATION 
SCHEDULE
The animals were divided into seven groups. Group I was injected with a single dose of 10 mg N of mucosal antigen dissolved in 0-5 ml Na Cl 0 (15 M and emulsified in an equal volume of Freund's complete adjuvant (FCA) H37Ra (Difco Laboratories, Detroit, Michigan). The adjuvant contains 1 mg/ml of killed human M tuberculosis. The emulsion was injected intradermally into the four foot pads and into the skin of the back at multiple sites, each animal receiving a total of 1 ml. They were killed at day 30 (10 animals Histological sections were examined in a coded fashion by one of us (MSN), without knowledge of the source of the slide, and whether from experimental or control animals.
Special care was taken in order to collect a maximum number of specimens upstream and downstream from the descending colon area neighbouring the contact zone with the MA-Alginate tablets.
At the time of death of the animals belonging to the experimental groups V, VI and VII, as well as their controls, the cannula used for the intraluminal challenge was re-introduced in order to precisely localise the original contact area with the immunogen. Only those animals retaining the tablets for at least six hours were studied.
For each of the experimental and control animals, representative pieces of kidney, liver, adrenal glands and lungs were fixed and processed as above.
Body weight was recorded daily for 10 days after immunisation and weekly later on. Visual examination of the anus was carried out in order to detect macroscopic blood loss. Weekly or biweekly cardiac blood samples were taken in order to measure the red cell volume (haematocrit). Immunoelectrophoretic and serologic studies (Nemirovsky, unpublished) reveal that those antibodies were mainly IgG y 2.
All samples collected from animals receiving a single dose of mucosal antigen as well as those from the controls gave negative results. An identity reaction was detected between the precipitation bands of heterologous and isologous anti-mucosal antigen antibodies, although some reactions of nonidentity can be observed (Fig. 1) .
CELL MEDIATED IMMUNE RESPONSES
The intradermal injection of mucosal antigen to alloimmunised animals produced a cutaneous reaction which was characterised by congestion and induration and which reached its peak 24 h after challenge. Thirteen out of 15 animals receiving a single dose of mucosal antigen and studied 30 days later gave positive skin tests (diameter of erythema B(10 mm; diameter of induration B5 mm). This in vivo delayed hypersensitivity reaction also gave positive results in guinea pigs receiving multiple doses of the immunogen, including those studied 225 days after the beginning of the immunisation Table Immunopathological features Fig. 1 mucosal antigen developed lesions which were preferentially localised in the ileum and descending colon. They were characterised by vascular congestion of the lamina propria, ulceration and haemorrhage (Fig. 2) .
Sometimes the loss of epithelium and the neighbouring lamina propria, including Leiberkhun glands, was quite extensive, but without microscopic evidence of blood loss.
Thirty days after immunisation, mononuclear cell infiltration of the lamina propria was an infrequent event. Twelve of the 15 guinea pigs belonging to groups I and V developed histological alterations in at least one intestinal segment.
In animals receiving multiple doses of mucosal antigen, epithelial loss, congestion, haemorrhage and destruction of villus architecture were prevailing lesions especially in the ileum (Fig. 3) . The caecum appeared to be more frequently affected than in single injected animals (Fig. 4) .
Even though already apparent 60 days after the beginning of the immunisation, lesions, characterised by extensive loss of the mucosal epithelium, mononuclear cell infiltration, cryptal degeneration and fibrocytic proliferation of the lamina propria, increased in severity at later periods (Figs 5 and 6 ).
The number of animals developing at least one Nemirovsky and Hugon form of histopathological alterations was as high as that of single challenged guinea pigs: 22/25. The animals receiving one or two doses of MA and challenged by the intracolonic route (groups V, VI and VII) developed the same kind of lesions as those belonging to groups I to IV. (Fig. 7) Notwithstanding, two characteristics have to be pointed out: (1) the congestion, edema, villus destruction and haemorrhage could also be detected in other segments of intestine such as duodenum, jejunum, ascending or transverse colon. These localisations were unusual in other experimental groups; (2) within the contact areas with the MA-alginate tablet, a heavy mononuclear cell infiltration could be detected at the time after immunisation when this histological feature was infrequent (Fig. 8) . At later periods, the mononuclear cell infiltration sometimes invaded the submucosa. Granuloma formation was observed in the lamina propria ( Figure 9 ).
The histological analysis of organs other than those belonging to the gut show no pathological alterations. The same was true for the control guinea pigs, either non-immunised or injected with FCA alone, including the intestine (Fig. 10) .
In control animals, only a very mild degree of vascular congestion could be detected at the alginate-MA contact areas. Fig It) Many of the models of non-specific bowel disease are concerned with the appearance of ulcerative lesions in colon or rectum. This is the main feature of lesions obtained by carragenin ingestion in guinea pigs'3 and rabbits.
Dilute acetic acid applied over the colonic serosa or per rectum in rats'5 or intraluminally at the caeco-colonic junction in rabbitsi6 provokes a diffuse colitis. Here, the ulceration and some degree of non-specific cellular infiltration are the main features.
In search of a less acute and more chronic type of colitis possessing some of the immunological elements present in inflammatory bowel diseases, Mee et al combined the immunisation of rabbits with the enterobacterial antigen of Kunin, with the injection of soluble immunocomplexes and a mild irritation of colon with diluted formalin. Still, in this interesting model, the lesions were limited to the colon.
The importance of cell mediated events in some models of inflammatory bowel disease has been stressed by dinitrochlorobenzene sensitisation experiments. -2 Our results obtained in alloimmunised guinea pigs challenged by the intraluminal colonic route, are compatible with an 'in vivo' delayed hypersensitivity reaction of the descending colonic mucosa. A distinctive feature of our observations, however, is that the reaction is accompanied by lesions located in anatomical segments far away from the original contact area with MAalginate.
The possibility is raised that in these experimental groups, a more intense immune response reaches segments not usually targeted, but nevertheless bearer of the putative autoantigen.
Further studies could confirm the usefulness of alloimmunisation with the mucosal antigen immunogen in the guinea pig, as a model for the study of inflammatory bowel disease.
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